Protocol Design White Papers & Case Studies
-
Driving Efficiency And ROI In Clinical Trials
11/19/2024
Integrate sensors into your study to evaluate digital endpoints with a comprehensive solution that accelerates drug development, reduces patient sample sizes, cuts costs, and improves patient insights.
-
Preparing CRAs For Success In Oncology: Targeted Training In An Era Of Advanced Therapeutics
11/18/2024
Explore the pivotal role of Clinical Research Associates (CRAs) in oncology clinical trials, emphasizing their critical responsibilities and the importance of specialized CRA training programs.
-
The Impact Of High Inflation And The Great Resignation On Clinical Site Budgeting
10/30/2024
The twin pressures of inflation and attrition prolong negotiations between sponsors and clinical sites, stalling drug development. Sponsors need up-to-date, reliable benchmark data to negotiate fair market value budgets.
-
A Promising Rebound in Clinical Trials
10/23/2024
This report explores how clinical trials bounced back in 2023 from their decline a year earlier despite continued geopolitical, regulatory, and pricing pressures.
-
The Importance Of A Maturity Model For Clinical Trial Transparency
10/23/2024
A comprehensive maturity model for clinical trial disclosure and transparency offers companies a strategic tool to assess and enhance their practices in an increasingly complex regulatory environment.
-
Real-World Value Realized From DHTs In Clinical Trials
10/22/2024
Explore four real-world examples of clinical trials that successfully integrated DHTs. Each case study highlights how DHTs impacted specific aspects of trial design.
-
Improving Patient Health And Safety: SOPs And Process Mapping
10/21/2024
In this study, a biotech company faced compliance challenges due to inadequate SOPs that lacked detailed process maps. Propharma stepped in to provide a strategy and project plan.
-
Successful Special Procedure Study Conduct: Cerebrospinal Fluid (CSF) And Concurrent Muscle Biopsy
10/17/2024
Worldwide assisted a trial sponsor with a study exploring a novel therapeutic protein (TP) in 48 healthy volunteers.
-
Partnering For Precision In An IPF Study: Securing Timely Deliverables And Key Endpoints
10/17/2024
A pharmaceutical company enlisted Worldwide Clinical Trials to help achieve on-time results for their Phase IIa IPF clinical trial, enabling them to manage vendors and meet challenging deadlines.
-
Cardiovascular Clinical Development
10/16/2024
Worldwide offers a full suite of services and a team of experts to support your cardiovascular therapy development and ensure your program's success throughout all clinical phases.